-
Study aim
-
determine the effect of different doses of vitamin D3 supplementation on anthropometric indexes, parameters of metabolic, bone, vascular and body composition in children and adolescents with overweight or obesity
-
Design
-
parallel group, single blind, randomized placebo-controlled clinical trial.
-
Settings and conduct
-
overweight and obesity children and adolescents of Tehran, Iran
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
- Willingness to cooperate
- Age 6-13 years
- Overweight or obesity
Exclusion criteria:
- Reluctance to cooperate in any stage of study
- Use of any vitamin D supplements
- Use of any drugs, affecting metabolism of vitamin D including glucocorticoids, steroids and anticonvulsants such as carbamazepine, phenytoin and phenobarbital
-
Intervention groups
-
Three intervention groups as follows:oral 2000 IU of vitamin D3 supplement, 1000 IU vitamin D3 supplement, and the control group (600 IU vitamin D3 supplement) for 12 months.
-
Main outcome variables
-
carotid intima media thickness (cIMT), 25 hydroxy vitamin D, parathormone, lipid profile, glucose, insulin, body mass index, fat mass, lean mass, systolic and diastolic blood pressure, calcium, phosphorus